Close Menu

A news story looks at how President Obama's proposed $825-billion economic stimulus bill might pan out, if passed into law. On paper, it looks good: the bill includes new funding of more than $13 billion, with the NSF receiving an additional $3 billion, the NIH, $3.5 billion, and the DOE's Office of Science, $2 billion. Critics, including Elias Zerhouni, say the bill focuses too much on short-term fixes. It's "too timid and not strategic enough in addressing the long term.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.